Semaglutide Dosing Guide: Titration, Timing & What Research Shows

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes management. It has gained significant attention for its effects on weight management, with FDA approval under brand names Ozempic® and Wegovy®.

Titration Schedule

Proper dose titration is critical for minimizing gastrointestinal side effects. The standard clinical titration follows a step-up pattern:

Week	Dose	Frequency
1-4	0.25mg	Once weekly
5-8	0.5mg	Once weekly
9-12	1.0mg	Once weekly
13-16	1.7mg	Once weekly
17+	2.4mg	Once weekly

Key Dosing Considerations

Injection Day Consistency: Research shows that maintaining the same injection day each week provides the most stable blood levels, thanks to semaglutide's ~7-day half-life.

Timing: Semaglutide can be administered at any time of day, with or without meals. Most researchers report best tolerance with morning or evening dosing.

Injection Sites: Abdomen, thigh, or upper arm. Rotate sites to prevent lipodystrophy.

Managing Side Effects

The most common side effects during titration include nausea, decreased appetite, and digestive discomfort. Strategies to manage these include:

Eating smaller, more frequent meals
Avoiding high-fat foods during titration
Staying well-hydrated
Slowing the titration schedule if needed

Evidence Quality

Semaglutide has High evidence quality with extensive Phase III clinical trial data (STEP Trials, SUSTAIN Trials). It is one of the most well-studied peptides in the current database.

Important Notes

Semaglutide is an FDA-approved medication. Research use should follow all applicable regulations and guidelines. Always consult institutional protocols before beginning any research program.